ID   ESA1_YEAST              Reviewed;         445 AA.
AC   Q08649; D6W2U6;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   18-JUN-2025, entry version 223.
DE   RecName: Full=Histone acetyltransferase ESA1 {ECO:0000305};
DE            EC=2.3.1.48 {ECO:0000269|PubMed:12368900, ECO:0000269|PubMed:17223684, ECO:0000269|PubMed:18245364, ECO:0000269|PubMed:22020126, ECO:0000269|PubMed:9520405};
DE   AltName: Full=Protein 2-hydroxyisobutyryltransferase ESA1 {ECO:0000305};
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:O94446};
DE   AltName: Full=Protein acetyltransferase ESA1 {ECO:0000305};
DE            EC=2.3.1.- {ECO:0000269|PubMed:22539722, ECO:0000269|PubMed:29765047};
DE   AltName: Full=Protein crotonyltransferase ESA1 {ECO:0000305};
DE            EC=2.3.1.- {ECO:0000269|PubMed:31699900};
GN   Name=ESA1 {ECO:0000303|PubMed:9520405, ECO:0000312|SGD:S000005770};
GN   OrderedLocusNames=YOR244W; ORFNames=O5257;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 96604 / S288c / FY1679;
RX   PubMed=8972580;
RX   DOI=10.1002/(sici)1097-0061(199612)12:15%3c1575::aid-yea45%3e3.0.co;2-e;
RA   Boyer J., Michaux G., Fairhead C., Gaillon L., Dujon B.;
RT   "Sequence and analysis of a 26.9 kb fragment from chromosome XV of the
RT   yeast Saccharomyces cerevisiae.";
RL   Yeast 12:1575-1586(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169874; DOI=10.1038/387s098;
RA   Dujon B., Albermann K., Aldea M., Alexandraki D., Ansorge W., Arino J.,
RA   Benes V., Bohn C., Bolotin-Fukuhara M., Bordonne R., Boyer J., Camasses A.,
RA   Casamayor A., Casas C., Cheret G., Cziepluch C., Daignan-Fornier B.,
RA   Dang V.-D., de Haan M., Delius H., Durand P., Fairhead C., Feldmann H.,
RA   Gaillon L., Galisson F., Gamo F.-J., Gancedo C., Goffeau A., Goulding S.E.,
RA   Grivell L.A., Habbig B., Hand N.J., Hani J., Hattenhorst U., Hebling U.,
RA   Hernando Y., Herrero E., Heumann K., Hiesel R., Hilger F., Hofmann B.,
RA   Hollenberg C.P., Hughes B., Jauniaux J.-C., Kalogeropoulos A.,
RA   Katsoulou C., Kordes E., Lafuente M.J., Landt O., Louis E.J., Maarse A.C.,
RA   Madania A., Mannhaupt G., Marck C., Martin R.P., Mewes H.-W., Michaux G.,
RA   Paces V., Parle-McDermott A.G., Pearson B.M., Perrin A., Pettersson B.,
RA   Poch O., Pohl T.M., Poirey R., Portetelle D., Pujol A., Purnelle B.,
RA   Ramezani Rad M., Rechmann S., Schwager C., Schweizer M., Sor F., Sterky F.,
RA   Tarassov I.A., Teodoru C., Tettelin H., Thierry A., Tobiasch E.,
RA   Tzermia M., Uhlen M., Unseld M., Valens M., Vandenbol M., Vetter I.,
RA   Vlcek C., Voet M., Volckaert G., Voss H., Wambutt R., Wedler H.,
RA   Wiemann S., Winsor B., Wolfe K.H., Zollner A., Zumstein E., Kleine K.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XV.";
RL   Nature 387:98-102(1997).
RN   [3]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF GLY-315.
RX   PubMed=9520405; DOI=10.1073/pnas.95.7.3561;
RA   Smith E.R., Eisen A., Gu W., Sattah M., Pannuti A., Zhou J., Cook R.G.,
RA   Lucchesi J.C., Allis C.D.;
RT   "ESA1 is a histone acetyltransferase that is essential for growth in
RT   yeast.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:3561-3565(1998).
RN   [5]
RP   IDENTIFICATION IN A NUA4 COMPLEX WITH TRA1.
RX   PubMed=10487762; DOI=10.1093/emboj/18.18.5108;
RA   Allard S., Utley R.T., Savard J., Clarke A.S., Grant P.A., Brandl C.J.,
RA   Pillus L., Workman J.L., Cote J.;
RT   "NuA4, an essential transcription adaptor/histone H4 acetyltransferase
RT   complex containing Esa1p and the ATM-related cofactor Tra1p.";
RL   EMBO J. 18:5108-5119(1999).
RN   [6]
RP   FUNCTION OF THE NUA4 COMPLEX.
RX   PubMed=9858608; DOI=10.1128/mcb.19.1.855;
RA   Ikeda K., Steger D.J., Eberharter A., Workman J.L.;
RT   "Activation domain-specific and general transcription stimulation by native
RT   histone acetyltransferase complexes.";
RL   Mol. Cell. Biol. 19:855-863(1999).
RN   [7]
RP   FUNCTION, AND ACETYLATION OF HISTONES H2A; H3 AND H4.
RX   PubMed=10082517; DOI=10.1128/mcb.19.4.2515;
RA   Clarke A.S., Lowell J.E., Jacobson S.J., Pillus L.;
RT   "Esa1p is an essential histone acetyltransferase required for cell cycle
RT   progression.";
RL   Mol. Cell. Biol. 19:2515-2526(1999).
RN   [8]
RP   FUNCTION OF THE NUA4 COMPLEX.
RX   PubMed=10835360; DOI=10.1093/emboj/19.11.2629;
RA   Vignali M., Steger D.J., Neely K.E., Workman J.L.;
RT   "Distribution of acetylated histones resulting from Gal4-VP16 recruitment
RT   of SAGA and NuA4 complexes.";
RL   EMBO J. 19:2629-2640(2000).
RN   [9]
RP   IDENTIFICATION IN THE NUA4 COMPLEX, FUNCTION OF THE NUA4 COMPLEX,
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH HISTONES H2A; H3 AND H4.
RX   PubMed=10911987; DOI=10.1016/s1097-2765(00)80258-0;
RA   Galarneau L., Nourani A., Boudreault A.A., Zhang Y., Heliot L., Allard S.,
RA   Savard J., Lane W.S., Stillman D.J., Cote J.;
RT   "Multiple links between the NuA4 histone acetyltransferase complex and
RT   epigenetic control of transcription.";
RL   Mol. Cell 5:927-937(2000).
RN   [10]
RP   ACETYLATION OF HISTONES H2A AND H4.
RX   PubMed=11100734; DOI=10.1038/35044127;
RA   Vogelauer M., Wu J., Suka N., Grunstein M.;
RT   "Global histone acetylation and deacetylation in yeast.";
RL   Nature 408:495-498(2000).
RN   [11]
RP   ACETYLATION OF HISTONES H2A; H2B AND H4.
RX   PubMed=11545749; DOI=10.1016/s1097-2765(01)00301-x;
RA   Suka N., Suka Y., Carmen A.A., Wu J., Grunstein M.;
RT   "Highly specific antibodies determine histone acetylation site usage in
RT   yeast heterochromatin and euchromatin.";
RL   Mol. Cell 8:473-479(2001).
RN   [12]
RP   DOMAIN, AND MUTAGENESIS OF TRP-247; ASN-250; LEU-251; CYS-252; LEU-253;
RP   LEU-254; LYS-256; LEU-259; ASP-260 AND LYS-262.
RX   PubMed=12110674; DOI=10.1074/jbc.m204640200;
RA   Adachi N., Kimura A., Horikoshi M.;
RT   "A conserved motif common to the histone acetyltransferase Esa1 and the
RT   histone deacetylase Rpd3.";
RL   J. Biol. Chem. 277:35688-35695(2002).
RN   [13]
RP   FUNCTION.
RX   PubMed=12353039; DOI=10.1038/nature01035;
RA   Bird A.W., Yu D.Y., Pray-Grant M.G., Qiu Q., Harmon K.E., Megee P.C.,
RA   Grant P.A., Smith M.M., Christman M.F.;
RT   "Acetylation of histone H4 by Esa1 is required for DNA double-strand break
RT   repair.";
RL   Nature 419:411-415(2002).
RN   [14]
RP   FUNCTION IN ACETYLATION OF HISTONE H4.
RX   PubMed=12379856; DOI=10.1038/ng1017;
RA   Suka N., Luo K., Grunstein M.;
RT   "Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine
RT   16 and spreading of heterochromatin.";
RL   Nat. Genet. 32:378-383(2002).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=14690591; DOI=10.1016/s1097-2765(03)00476-3;
RA   Hazbun T.R., Malmstroem L., Anderson S., Graczyk B.J., Fox B., Riffle M.,
RA   Sundin B.A., Aranda J.D., McDonald W.H., Chiu C.-H., Snydsman B.E.,
RA   Bradley P., Muller E.G.D., Fields S., Baker D., Yates J.R. III, Davis T.N.;
RT   "Assigning function to yeast proteins by integration of technologies.";
RL   Mol. Cell 12:1353-1365(2003).
RN   [16]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [17]
RP   FUNCTION OF THE NUA4 COMPLEX.
RX   PubMed=15175650; DOI=10.1038/sj.emboj.7600230;
RA   Nourani A., Utley R.T., Allard S., Cote J.;
RT   "Recruitment of the NuA4 complex poises the PHO5 promoter for chromatin
RT   remodeling and activation.";
RL   EMBO J. 23:2597-2607(2004).
RN   [18]
RP   FUNCTION.
RX   PubMed=15494307; DOI=10.1016/j.molcel.2004.09.021;
RA   Robert F., Pokholok D.K., Hannett N.M., Rinaldi N.J., Chandy M., Rolfe A.,
RA   Workman J.L., Gifford D.K., Young R.A.;
RT   "Global position and recruitment of HATs and HDACs in the yeast genome.";
RL   Mol. Cell 16:199-209(2004).
RN   [19]
RP   FUNCTION, IDENTIFICATION IN THE NUA4 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15045029; DOI=10.1371/journal.pbio.0020131;
RA   Kobor M.S., Venkatasubrahmanyam S., Meneghini M.D., Gin J.W.,
RA   Jennings J.L., Link A.J., Madhani H.D., Rine J.;
RT   "A protein complex containing the conserved Swi2/Snf2-related ATPase Swr1p
RT   deposits histone variant H2A.Z into euchromatin.";
RL   PLoS Biol. 2:587-599(2004).
RN   [20]
RP   IDENTIFICATION IN THE NUA4 COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=15353583; DOI=10.1073/pnas.0405753101;
RA   Krogan N.J., Baetz K., Keogh M.-C., Datta N., Sawa C., Kwok T.C.Y.,
RA   Thompson N.J., Davey M.G., Pootoolal J., Hughes T.R., Emili A.,
RA   Buratowski S., Hieter P., Greenblatt J.F.;
RT   "Regulation of chromosome stability by the histone H2A variant Htz1, the
RT   Swr1 chromatin remodeling complex, and the histone acetyltransferase
RT   NuA4.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:13513-13518(2004).
RN   [21]
RP   REGULATION BY HISTONE H3 METHYLATION.
RX   PubMed=15949446; DOI=10.1016/j.molcel.2005.05.009;
RA   Morillon A., Karabetsou N., Nair A., Mellor J.;
RT   "Dynamic lysine methylation on histone H3 defines the regulatory phase of
RT   gene transcription.";
RL   Mol. Cell 18:723-734(2005).
RN   [22]
RP   FUNCTION.
RX   PubMed=15923609; DOI=10.1128/mcb.25.12.4903-4913.2005;
RA   Tamburini B.A., Tyler J.K.;
RT   "Localized histone acetylation and deacetylation triggered by the
RT   homologous recombination pathway of double-strand DNA repair.";
RL   Mol. Cell. Biol. 25:4903-4913(2005).
RN   [23]
RP   DOMAIN.
RX   PubMed=15964809; DOI=10.1128/mcb.25.13.5535-5542.2005;
RA   Selleck W., Fortin I., Sermwittayawong D., Cote J., Tan S.;
RT   "The Saccharomyces cerevisiae Piccolo NuA4 histone acetyltransferase
RT   complex requires the Enhancer of Polycomb A domain and chromodomain to
RT   acetylate nucleosomes.";
RL   Mol. Cell. Biol. 25:5535-5542(2005).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-17, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [25]
RP   FUNCTION IN ACETYLATION OF HISTONE H2A VARIANT HTZ1.
RX   PubMed=16543223; DOI=10.1101/gad.1395506;
RA   Millar C.B., Xu F., Zhang K., Grunstein M.;
RT   "Acetylation of H2AZ Lys 14 is associated with genome-wide gene activity in
RT   yeast.";
RL   Genes Dev. 20:711-722(2006).
RN   [26]
RP   CATALYTIC ACTIVITY, MUTAGENESIS OF CYS-304 AND GLU-338, AND ACTIVE SITE.
RX   PubMed=17223684; DOI=10.1021/bi602513x;
RA   Berndsen C.E., Albaugh B.N., Tan S., Denu J.M.;
RT   "Catalytic mechanism of a MYST family histone acetyltransferase.";
RL   Biochemistry 46:623-629(2007).
RN   [27]
RP   FUNCTION, MUTAGENESIS OF CYS-304 AND GLU-338, CATALYTIC ACTIVITY, AND
RP   ACTIVE SITE.
RX   PubMed=18245364; DOI=10.1534/genetics.107.080135;
RA   Decker P.V., Yu D.Y., Iizuka M., Qiu Q., Smith M.M.;
RT   "Catalytic-site mutations in the MYST family histone Acetyltransferase
RT   Esa1.";
RL   Genetics 178:1209-1220(2008).
RN   [28]
RP   FUNCTION.
RX   PubMed=19822662; DOI=10.1128/mcb.01033-09;
RA   Ginsburg D.S., Govind C.K., Hinnebusch A.G.;
RT   "NuA4 lysine acetyltransferase Esa1 is targeted to coding regions and
RT   stimulates transcription elongation with Gcn5.";
RL   Mol. Cell. Biol. 29:6473-6487(2009).
RN   [29]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=22539722; DOI=10.1126/science.1216990;
RA   Yi C., Ma M., Ran L., Zheng J., Tong J., Zhu J., Ma C., Sun Y., Zhang S.,
RA   Feng W., Zhu L., Le Y., Gong X., Yan X., Hong B., Jiang F.J., Xie Z.,
RA   Miao D., Deng H., Yu L.;
RT   "Function and molecular mechanism of acetylation in autophagy regulation.";
RL   Science 336:474-477(2012).
RN   [30]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=29765047; DOI=10.1038/s41467-018-04363-w;
RA   Li T.Y., Song L., Sun Y., Li J., Yi C., Lam S.M., Xu D., Zhou L., Li X.,
RA   Yang Y., Zhang C.S., Xie C., Huang X., Shui G., Lin S.Y., Reue K.,
RA   Lin S.C.;
RT   "Tip60-mediated lipin 1 acetylation and ER translocation determine
RT   triacylglycerol synthesis rate.";
RL   Nat. Commun. 9:1916-1916(2018).
RN   [31]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=31699900; DOI=10.1074/jbc.ra119.010302;
RA   Kollenstart L., de Groot A.J.L., Janssen G.M.C., Cheng X., Vreeken K.,
RA   Martino F., Cote J., van Veelen P.A., van Attikum H.;
RT   "Gcn5 and Esa1 function as histone crotonyltransferases to regulate
RT   crotonylation-dependent transcription.";
RL   J. Biol. Chem. 294:20122-20134(2019).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 160-435 IN COMPLEX WITH COENZYME
RP   A.
RX   PubMed=11106757; DOI=10.1016/s1097-2765(00)00116-7;
RA   Yan Y., Barlev N.A., Haley R.H., Berger S.L., Marmorstein R.;
RT   "Crystal structure of yeast Esa1 suggests a unified mechanism for catalysis
RT   and substrate binding by histone acetyltransferases.";
RL   Mol. Cell 6:1195-1205(2000).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.26 ANGSTROMS) OF 162-435 OF MUTANTS GLN-338 AND
RP   CYS-304 IN COMPLEX WITH ACETYL-COA, CATALYTIC ACTIVITY, ACTIVE SITE, AND
RP   MUTAGENESIS OF CYS-304 AND GLU-338.
RX   PubMed=12368900; DOI=10.1038/nsb849;
RA   Yan Y., Harper S., Speicher D.W., Marmorstein R.;
RT   "The catalytic mechanism of the ESA1 histone acetyltransferase involves a
RT   self-acetylated intermediate.";
RL   Nat. Struct. Biol. 9:862-869(2002).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 160-435 IN COMPLEXES WITH
RP   ACETYL-COA ANALOGS, CATALYTIC ACTIVITY, ACTIVE SITE, ACETYLATION AT
RP   LYS-262, AND MUTAGENESIS OF LYS-262.
RX   PubMed=22020126; DOI=10.1038/emboj.2011.382;
RA   Yuan H., Rossetto D., Mellert H., Dang W., Srinivasan M., Johnson J.,
RA   Hodawadekar S., Ding E.C., Speicher K., Abshiru N., Perry R., Wu J.,
RA   Yang C., Zheng Y.G., Speicher D.W., Thibault P., Verreault A.,
RA   Johnson F.B., Berger S.L., Sternglanz R., McMahon S.B., Cote J.,
RA   Marmorstein R.;
RT   "MYST protein acetyltransferase activity requires active site lysine
RT   autoacetylation.";
RL   EMBO J. 31:58-70(2012).
CC   -!- FUNCTION: Catalytic component of the NuA4 histone acetyltransferase
CC       (HAT), a multiprotein complex involved in epigenetic transcriptional
CC       activation of selected genes principally by acetylation of nucleosomal
CC       histones H4, H3, H2B, H2A and H2A variant H2A.Z (PubMed:10082517,
CC       PubMed:10835360, PubMed:10911987, PubMed:12353039, PubMed:12379856,
CC       PubMed:15045029, PubMed:15175650, PubMed:15494307, PubMed:15923609,
CC       PubMed:16543223, PubMed:18245364, PubMed:9520405, PubMed:9858608).
CC       Acetylates histone H4 to form H4K5ac, H4K8ac, H4K12ac and H4K16ac,
CC       histone H3 to form H3K14ac, histone H2B to form H2BK16ac, histone H2A
CC       to form H2AK4ac and H2AK7ac, and histone variant H2A.Z to form
CC       H2A.ZK14ac (PubMed:10082517, PubMed:10835360, PubMed:10911987,
CC       PubMed:12353039, PubMed:15045029, PubMed:15175650, PubMed:15494307,
CC       PubMed:15923609, PubMed:18245364, PubMed:9858608). Acetylation of
CC       histones gives a specific tag for epigenetic transcription initiation
CC       and elongation (PubMed:16543223, PubMed:19822662). Acetylation of
CC       histone H4 is essential for DNA double-strand break repair through
CC       homologous recombination (PubMed:10082517, PubMed:10835360,
CC       PubMed:10911987, PubMed:12353039, PubMed:15045029, PubMed:15175650,
CC       PubMed:15494307, PubMed:15923609, PubMed:18245364, PubMed:9858608).
CC       Involved in cell cycle progression (PubMed:10082517, PubMed:10835360,
CC       PubMed:10911987, PubMed:12353039, PubMed:15045029, PubMed:15175650,
CC       PubMed:15494307, PubMed:15923609, PubMed:18245364, PubMed:9858608).
CC       Recruitment to promoters depends on H3K4me (PubMed:10082517,
CC       PubMed:10835360, PubMed:10911987, PubMed:12353039, PubMed:15045029,
CC       PubMed:15175650, PubMed:15494307, PubMed:15923609, PubMed:18245364,
CC       PubMed:9858608). Also acetylates non-histone proteins, such as ATG3 and
CC       PAH1 (PubMed:22539722, PubMed:29765047). Regulates autophagy by
CC       acetylating ATG3, controlling interaction the interaction between ATG3
CC       and ATG8 and ATG8 lipidation (PubMed:22539722). Acts as a regulator of
CC       fatty-acid-induced triacylglycerol synthesis by catalyzing acetylation
CC       of PAH1, thereby promoting the synthesis of diacylglycerol
CC       (PubMed:29765047). In addition to protein acetyltransferase, can use
CC       different acyl-CoA substrates, such as 2-hydroxyisobutanoyl-CoA (2-
CC       hydroxyisobutyryl-CoA) or (2E)-butenoyl-CoA (crotonyl-CoA), and is able
CC       to mediate protein 2-hydroxyisobutyrylation and crotonylation,
CC       respectively (PubMed:31699900). Catalyzes histone crotonylation
CC       (PubMed:31699900). {ECO:0000269|PubMed:10082517,
CC       ECO:0000269|PubMed:10835360, ECO:0000269|PubMed:10911987,
CC       ECO:0000269|PubMed:12353039, ECO:0000269|PubMed:12379856,
CC       ECO:0000269|PubMed:15045029, ECO:0000269|PubMed:15175650,
CC       ECO:0000269|PubMed:15494307, ECO:0000269|PubMed:15923609,
CC       ECO:0000269|PubMed:16543223, ECO:0000269|PubMed:18245364,
CC       ECO:0000269|PubMed:19822662, ECO:0000269|PubMed:22539722,
CC       ECO:0000269|PubMed:29765047, ECO:0000269|PubMed:31699900,
CC       ECO:0000269|PubMed:9520405, ECO:0000269|PubMed:9858608}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl-[histone] + acetyl-CoA = N(6)-acetyl-L-lysyl-[histone]
CC         + CoA + H(+); Xref=Rhea:RHEA:21992, Rhea:RHEA-COMP:9845, Rhea:RHEA-
CC         COMP:11338, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000269|PubMed:12368900, ECO:0000269|PubMed:17223684,
CC         ECO:0000269|PubMed:18245364, ECO:0000269|PubMed:22020126,
CC         ECO:0000269|PubMed:9520405};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21993;
CC         Evidence={ECO:0000269|PubMed:12368900, ECO:0000269|PubMed:17223684,
CC         ECO:0000269|PubMed:18245364, ECO:0000269|PubMed:22020126,
CC         ECO:0000269|PubMed:9520405};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl-[protein] + acetyl-CoA = N(6)-acetyl-L-lysyl-[protein]
CC         + CoA + H(+); Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752, Rhea:RHEA-
CC         COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:57288, ChEBI:CHEBI:61930;
CC         Evidence={ECO:0000269|PubMed:22539722, ECO:0000269|PubMed:29765047};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45949;
CC         Evidence={ECO:0000269|PubMed:22539722, ECO:0000269|PubMed:29765047};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxyisobutanoyl-CoA + L-lysyl-[protein] = N(6)-(2-
CC         hydroxyisobutanoyl)-L-lysyl-[protein] + CoA + H(+);
CC         Xref=Rhea:RHEA:24180, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:15921,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287,
CC         ChEBI:CHEBI:131780, ChEBI:CHEBI:144968;
CC         Evidence={ECO:0000250|UniProtKB:O94446};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24181;
CC         Evidence={ECO:0000250|UniProtKB:O94446};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-butenoyl-CoA + L-lysyl-[protein] = N(6)-(2E)-butenoyl-L-
CC         lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:53908, Rhea:RHEA-
CC         COMP:9752, Rhea:RHEA-COMP:13707, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57332,
CC         ChEBI:CHEBI:137954; Evidence={ECO:0000269|PubMed:31699900};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:53909;
CC         Evidence={ECO:0000269|PubMed:31699900};
CC   -!- SUBUNIT: Component of the NuA4 histone acetyltransferase complex
CC       composed of at least ACT1, ARP4, EAF3, EAF5, EAF6, EAF7, EPL1, ESA1,
CC       SWC4, TRA1, VID21, YAF9 and YNG2. The complex interacts with histones
CC       H4 (HHF1 and HHF2), H3 (HHT1 and HHT2) and H2A (HTA1 and HTA2).
CC       {ECO:0000269|PubMed:10487762, ECO:0000269|PubMed:10911987,
CC       ECO:0000269|PubMed:11106757, ECO:0000269|PubMed:12368900,
CC       ECO:0000269|PubMed:15045029, ECO:0000269|PubMed:15353583}.
CC   -!- INTERACTION:
CC       Q08649; P80428: ARP4; NbExp=10; IntAct=EBI-6648, EBI-2939;
CC       Q08649; Q12432: EAF3; NbExp=12; IntAct=EBI-6648, EBI-6281;
CC       Q08649; P02309: HHF2; NbExp=5; IntAct=EBI-6648, EBI-8113;
CC       Q08649; P11938: RAP1; NbExp=6; IntAct=EBI-6648, EBI-14821;
CC       Q08649; P38811: TRA1; NbExp=11; IntAct=EBI-6648, EBI-24638;
CC   -!- DOMAIN: The ESA1-RPD3 motif is common to ESA1 and RPD3 and is required
CC       for ESA1 histone acetyl-transferase (HAT) activity and RPD3 histone
CC       deacetylase (HDAC) activity. {ECO:0000269|PubMed:12110674,
CC       ECO:0000269|PubMed:15964809}.
CC   -!- PTM: Autoacetylation at Lys-262 is required for proper function.
CC       {ECO:0000269|PubMed:22020126}.
CC   -!- MISCELLANEOUS: Present with 1170 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   -!- CAUTION: The catalytic mechanisms is still under debate. Cys-304 was
CC       proposed to function as a nucleophile that forms a covalent
CC       intermediate with acetyl-CoA during the reaction (PubMed:12368900), and
CC       indeed the residue can be acetylated (in vitro) (PubMed:12368900,
CC       PubMed:17223684). Depending on the assay system, mutation of Cys-304
CC       leads to reduced or undetectable activity, indicating that is plays an
CC       important role. Still, mutation of Cys-304 has only a minor effect on
CC       the catalytic activity of the NuA4 histone acetyltransferase (HAT)
CC       complex (PubMed:17223684), making it unlikely that this residue
CC       functions as the catalytic nucleophile. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z75152; CAA99465.1; -; Genomic_DNA.
DR   EMBL; BK006948; DAA11012.1; -; Genomic_DNA.
DR   PIR; S67137; S67137.
DR   RefSeq; NP_014887.3; NM_001183663.3.
DR   PDB; 1FY7; X-ray; 2.00 A; A=160-435.
DR   PDB; 1MJ9; X-ray; 2.50 A; A=160-435.
DR   PDB; 1MJA; X-ray; 2.26 A; A=160-435.
DR   PDB; 1MJB; X-ray; 2.50 A; A=160-435.
DR   PDB; 2RNZ; NMR; -; A=17-89.
DR   PDB; 2RO0; NMR; -; A=1-89.
DR   PDB; 3TO6; X-ray; 2.10 A; A=160-435.
DR   PDB; 3TO7; X-ray; 1.90 A; A=160-435.
DR   PDB; 3TO9; X-ray; 2.00 A; A=160-435.
DR   PDB; 5J9Q; X-ray; 3.25 A; A/E/I=141-445.
DR   PDB; 5J9T; X-ray; 2.70 A; A/E/I=141-445.
DR   PDB; 5J9U; X-ray; 2.95 A; A/E/I=141-445.
DR   PDB; 5J9W; X-ray; 2.80 A; A/E/I=141-445.
DR   PDB; 7VVU; EM; 3.40 A; P=1-445.
DR   PDB; 7VVZ; EM; 8.80 A; P=1-445.
DR   PDBsum; 1FY7; -.
DR   PDBsum; 1MJ9; -.
DR   PDBsum; 1MJA; -.
DR   PDBsum; 1MJB; -.
DR   PDBsum; 2RNZ; -.
DR   PDBsum; 2RO0; -.
DR   PDBsum; 3TO6; -.
DR   PDBsum; 3TO7; -.
DR   PDBsum; 3TO9; -.
DR   PDBsum; 5J9Q; -.
DR   PDBsum; 5J9T; -.
DR   PDBsum; 5J9U; -.
DR   PDBsum; 5J9W; -.
DR   PDBsum; 7VVU; -.
DR   PDBsum; 7VVZ; -.
DR   AlphaFoldDB; Q08649; -.
DR   BMRB; Q08649; -.
DR   EMDB; EMD-32150; -.
DR   SMR; Q08649; -.
DR   BioGRID; 34635; 945.
DR   ComplexPortal; CPX-3155; NuA4 histone acetyltransferase complex.
DR   ComplexPortal; CPX-3185; Piccolo NuA4 histone acetyltransferase complex.
DR   DIP; DIP-4115N; -.
DR   FunCoup; Q08649; 1137.
DR   IntAct; Q08649; 43.
DR   MINT; Q08649; -.
DR   STRING; 4932.YOR244W; -.
DR   ChEMBL; CHEMBL3832954; -.
DR   GlyGen; Q08649; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q08649; -.
DR   PaxDb; 4932-YOR244W; -.
DR   PeptideAtlas; Q08649; -.
DR   EnsemblFungi; YOR244W_mRNA; YOR244W; YOR244W.
DR   GeneID; 854418; -.
DR   KEGG; sce:YOR244W; -.
DR   AGR; SGD:S000005770; -.
DR   SGD; S000005770; ESA1.
DR   VEuPathDB; FungiDB:YOR244W; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   GeneTree; ENSGT00940000174488; -.
DR   HOGENOM; CLU_011815_2_0_1; -.
DR   InParanoid; Q08649; -.
DR   OMA; QYQRHGY; -.
DR   OrthoDB; 787137at2759; -.
DR   BioCyc; YEAST:G3O-33738-MONOMER; -.
DR   BRENDA; 2.3.1.48; 984.
DR   Reactome; R-SCE-2559586; DNA Damage/Telomere Stress Induced Senescence.
DR   Reactome; R-SCE-5693548; Sensing of DNA Double Strand Breaks.
DR   Reactome; R-SCE-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-SCE-9018519; Estrogen-dependent gene expression.
DR   BioGRID-ORCS; 854418; 5 hits in 10 CRISPR screens.
DR   EvolutionaryTrace; Q08649; -.
DR   PRO; PR:Q08649; -.
DR   Proteomes; UP000002311; Chromosome XV.
DR   RNAct; Q08649; protein.
DR   GO; GO:0000785; C:chromatin; IDA:SGD.
DR   GO; GO:0035267; C:NuA4 histone acetyltransferase complex; IDA:SGD.
DR   GO; GO:0000786; C:nucleosome; IDA:ComplexPortal.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0032777; C:piccolo histone acetyltransferase complex; IDA:SGD.
DR   GO; GO:0003682; F:chromatin binding; IBA:GO_Central.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:SGD.
DR   GO; GO:0140068; F:histone crotonyltransferase activity; IDA:SGD.
DR   GO; GO:0010485; F:histone H4 acetyltransferase activity; IDA:SGD.
DR   GO; GO:0106226; F:peptide 2-hydroxyisobutyryltransferase activity; IEA:RHEA.
DR   GO; GO:0061733; F:protein-lysine-acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; IDA:SGD.
DR   GO; GO:0006281; P:DNA repair; IDA:SGD.
DR   GO; GO:0006351; P:DNA-templated transcription; NAS:ComplexPortal.
DR   GO; GO:0006354; P:DNA-templated transcription elongation; IDA:SGD.
DR   GO; GO:0016239; P:positive regulation of macroautophagy; IMP:SGD.
DR   GO; GO:0032968; P:positive regulation of transcription elongation by RNA polymerase II; IMP:SGD.
DR   GO; GO:0010867; P:positive regulation of triglyceride biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0000183; P:rDNA heterochromatin formation; IMP:SGD.
DR   GO; GO:0051726; P:regulation of cell cycle; IMP:SGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:SGD.
DR   CDD; cd18986; CBD_ESA1_like; 1.
DR   CDD; cd04301; NAT_SF; 1.
DR   FunFam; 1.10.10.10:FF:000526; Histone acetyltransferase; 1.
DR   FunFam; 2.30.30.140:FF:000131; Histone acetyltransferase; 1.
DR   FunFam; 3.30.60.60:FF:000001; Histone acetyltransferase; 1.
DR   FunFam; 3.40.630.30:FF:000002; Histone acetyltransferase; 1.
DR   Gene3D; 2.30.30.140; -; 1.
DR   Gene3D; 3.40.630.30; -; 1.
DR   Gene3D; 3.30.60.60; N-acetyl transferase-like; 1.
DR   Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR016197; Chromo-like_dom_sf.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR050603; MYST_HAT.
DR   InterPro; IPR025995; Tudor-knot.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR040706; Zf-MYST.
DR   PANTHER; PTHR10615; HISTONE ACETYLTRANSFERASE; 1.
DR   PANTHER; PTHR10615:SF218; HISTONE ACETYLTRANSFERASE ESA1; 1.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF11717; Tudor-knot; 1.
DR   Pfam; PF17772; zf-MYST; 1.
DR   SMART; SM00298; CHROMO; 1.
DR   SUPFAM; SSF55729; Acyl-CoA N-acyltransferases (Nat); 1.
DR   SUPFAM; SSF54160; Chromo domain-like; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Chromatin regulator; DNA damage;
KW   DNA repair; Phosphoprotein; Reference proteome; Transcription;
KW   Transcription regulation; Transferase.
FT   CHAIN           1..445
FT                   /note="Histone acetyltransferase ESA1"
FT                   /id="PRO_0000051562"
FT   DOMAIN          22..74
FT                   /note="Tudor-knot"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          162..433
FT                   /note="MYST-type HAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   ZN_FING         195..220
FT                   /note="C2HC MYST-type; degenerate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   REGION          88..114
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           245..266
FT                   /note="ESA1-RPD3 motif"
FT   COMPBIAS        99..109
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        338
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000303|PubMed:12368900,
FT                   ECO:0000303|PubMed:17223684, ECO:0000303|PubMed:18245364,
FT                   ECO:0000303|PubMed:22020126, ECO:0000305"
FT   BINDING         303..307
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000269|PubMed:11106757,
FT                   ECO:0000269|PubMed:12368900, ECO:0000269|PubMed:22020126"
FT   BINDING         312..318
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000269|PubMed:11106757,
FT                   ECO:0000269|PubMed:12368900, ECO:0000269|PubMed:22020126"
FT   BINDING         342
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000269|PubMed:11106757,
FT                   ECO:0000269|PubMed:12368900, ECO:0000269|PubMed:22020126"
FT   SITE            304
FT                   /note="Important for catalytic activity"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         17
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18407956"
FT   MOD_RES         262
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:22020126"
FT   MUTAGEN         247
FT                   /note="W->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         250
FT                   /note="N->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         251
FT                   /note="L->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         252
FT                   /note="C->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         253
FT                   /note="L->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         254
FT                   /note="L->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         256
FT                   /note="K->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         259
FT                   /note="L->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         260
FT                   /note="D->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         262
FT                   /note="K->A: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:12110674"
FT   MUTAGEN         262
FT                   /note="K->R: Strongly reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:22020126"
FT   MUTAGEN         304
FT                   /note="C->A: Reduces HAT activity."
FT                   /evidence="ECO:0000269|PubMed:17223684"
FT   MUTAGEN         304
FT                   /note="C->S: Strongly reduces HAT activity, but is not
FT                   lethal (in vivo). Lethal, when associated with Q-338."
FT                   /evidence="ECO:0000269|PubMed:12368900,
FT                   ECO:0000269|PubMed:17223684, ECO:0000269|PubMed:18245364"
FT   MUTAGEN         315
FT                   /note="G->E: Loss of function."
FT                   /evidence="ECO:0000269|PubMed:9520405"
FT   MUTAGEN         338
FT                   /note="E->Q: Strongly reduces HAT activity at pH 9.2.
FT                   Nearly abolishes HAT activity at pH 8.0, but is not lethal
FT                   (in vivo). Lethal; when associated with S-334."
FT                   /evidence="ECO:0000269|PubMed:12368900,
FT                   ECO:0000269|PubMed:17223684, ECO:0000269|PubMed:18245364"
FT   STRAND          11..13
FT                   /evidence="ECO:0007829|PDB:2RO0"
FT   HELIX           18..20
FT                   /evidence="ECO:0007829|PDB:2RNZ"
FT   STRAND          25..30
FT                   /evidence="ECO:0007829|PDB:2RNZ"
FT   STRAND          35..44
FT                   /evidence="ECO:0007829|PDB:2RNZ"
FT   STRAND          46..49
FT                   /evidence="ECO:0007829|PDB:2RNZ"
FT   STRAND          51..55
FT                   /evidence="ECO:0007829|PDB:2RNZ"
FT   STRAND          65..68
FT                   /evidence="ECO:0007829|PDB:2RNZ"
FT   TURN            69..71
FT                   /evidence="ECO:0007829|PDB:2RNZ"
FT   STRAND          74..76
FT                   /evidence="ECO:0007829|PDB:2RNZ"
FT   STRAND          78..80
FT                   /evidence="ECO:0007829|PDB:2RO0"
FT   HELIX           161..163
FT                   /evidence="ECO:0007829|PDB:5J9T"
FT   STRAND          169..172
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          175..177
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           187..191
FT                   /evidence="ECO:0007829|PDB:5J9T"
FT   STRAND          194..197
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   TURN            199..201
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          204..207
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           208..215
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          224..230
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          232..240
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           241..243
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           245..256
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          271..280
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          283..295
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          300..303
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          305..307
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           309..311
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          313..315
FT                   /evidence="ECO:0007829|PDB:1FY7"
FT   HELIX           316..330
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          335..337
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           343..363
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          366..369
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           370..377
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           381..390
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          394..397
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   STRAND          400..404
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           407..418
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   HELIX           426..428
FT                   /evidence="ECO:0007829|PDB:3TO7"
FT   TURN            438..440
FT                   /evidence="ECO:0007829|PDB:5J9U"
SQ   SEQUENCE   445 AA;  52613 MW;  9E970F744D0B9E18 CRC64;
     MSHDGKEEPG IAKKINSVDD IIIKCQCWVQ KNDEERLAEI LSINTRKAPP KFYVHYVNYN
     KRLDEWITTD RINLDKEVLY PKLKATDEDN KKQKKKKATN TSETPQDSLQ DGVDGFSREN
     TDVMDLDNLN VQGIKDENIS HEDEIKKLRT SGSMTQNPHE VARVRNLNRI IMGKYEIEPW
     YFSPYPIELT DEDFIYIDDF TLQYFGSKKQ YERYRKKCTL RHPPGNEIYR DDYVSFFEID
     GRKQRTWCRN LCLLSKLFLD HKTLYYDVDP FLFYCMTRRD ELGHHLVGYF SKEKESADGY
     NVACILTLPQ YQRMGYGKLL IEFSYELSKK ENKVGSPEKP LSDLGLLSYR AYWSDTLITL
     LVEHQKEITI DEISSMTSMT TTDILHTAKT LNILRYYKGQ HIIFLNEDIL DRYNRLKAKK
     RRTIDPNRLI WKPPVFTASQ LRFAW
//
